2017 version of LI-RADS for CT and MR imaging: an update
The Liver Imaging Reporting and Data System (LI-RADS) is a reporting system created for
the standardized interpretation of liver imaging findings in patients who are at risk for …
the standardized interpretation of liver imaging findings in patients who are at risk for …
[HTML][HTML] MRI of hepatocellular carcinoma: an update of current practices
H Arif-Tiwari, B Kalb, S Chundru, P Sharma… - Diagnostic and …, 2014 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide, and liver
transplantation is the optimal treatment for selected patients with HCC and chronic liver …
transplantation is the optimal treatment for selected patients with HCC and chronic liver …
Proposal for a structured reporting system for prostate-specific membrane antigen–targeted PET imaging: PSMA-RADS version 1.0
As medical imaging has grown progressively more complicated and subspecialized in
recent decades, several standardized reporting systems have been proposed for a variety of …
recent decades, several standardized reporting systems have been proposed for a variety of …
[HTML][HTML] PSMA-RADS version 1.0: a step towards standardizing the interpretation and reporting of PSMA-targeted PET imaging studies
Beginning in 2012,[18F]-and [68Ga]-labeled inhibitors of prostate-specific membrane
antigen (PSMA) entered early clinical development for positron emission tomography (PET) …
antigen (PSMA) entered early clinical development for positron emission tomography (PET) …
Australian recommendations for the management of hepatocellular carcinoma: a consensus statement
JS Lubel, SK Roberts, SI Strasser… - Medical Journal of …, 2021 - Wiley Online Library
Introduction Hepatocellular carcinoma (HCC) is a leading cause of cancer deaths both
globally and in Australia. Surveillance for HCC in atrisk populations allows diagnosis at an …
globally and in Australia. Surveillance for HCC in atrisk populations allows diagnosis at an …
[PDF][PDF] Squaring the circle of selection and allocation in liver transplantation for HCC: an adaptive approach
V Mazzaferro - Hepatology, 2016 - Wiley Online Library
(HCC) is debated worldwide during rounds, publications, meetings, and—more importantly—
in front of patients with liver cancer who are seeking their doctors' advice, often after the …
in front of patients with liver cancer who are seeking their doctors' advice, often after the …
Generative adversarial networks for the creation of realistic artificial brain magnetic resonance images
Generative Adversarial Networks for the Creation of Realistic Artificial Brain Magnetic
Resonance Images Page 1 Generative Adversarial Networks for the Creation of Realistic …
Resonance Images Page 1 Generative Adversarial Networks for the Creation of Realistic …
Imaging outcomes of liver imaging reporting and data system version 2014 category 2, 3, and 4 observations detected at CT and MR imaging
M Tanabe, A Kanki, T Wolfson, EAC Costa… - Radiology, 2016 - pubs.rsna.org
Purpose To determine the proportion of untreated Liver Imaging Reporting and Data System
(LI-RADS) version 2014 category 2, 3, and 4 observations that progress, remain stable, or …
(LI-RADS) version 2014 category 2, 3, and 4 observations that progress, remain stable, or …
Irreversible electroporation to treat unresectable colorectal liver metastases (COLDFIRE-2): a phase II, two-center, single-arm clinical trial
MR Meijerink, AH Ruarus, LGPH Vroomen, RS Puijk… - Radiology, 2021 - pubs.rsna.org
Background Irreversible electroporation (IRE), an ablative technique that uses high-voltage
electrical pulses, has shown promise for eradicating tumors near critical structures, including …
electrical pulses, has shown promise for eradicating tumors near critical structures, including …
Differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging
Objectives To determine the different imaging features of intrahepatic mass-forming
cholangiocarcinoma (IMCC) from hepatocellular carcinoma (HCC) on gadoxetic acid …
cholangiocarcinoma (IMCC) from hepatocellular carcinoma (HCC) on gadoxetic acid …